Archive for March 2018
Taneli Jouhikainen, MD, PhD
Dr. Taneli Jouhikainen is a Co-Founder of Savara and has served as Chief Operating Officer since October 2009. From October 2006 until September 2009, he served at Akela Pharma Inc., a public clinical stage specialty pharmaceutical company focused on orphan drugs and inhalation products, first as Head of Corporate Development and subsequently as interim CEO…
Read MoreGregory Grunberg, MD
Dr. Grunberg is a Managing Director of Longitude Capital. Prior to joining Longitude Capital in 2012, Dr. Grunberg was a Principal at Rho Ventures and an Engagement Manager at McKinsey & Company. Dr. Grunberg is a board-certified physician in Internal Medicine and completed his residency at Cornell’s New York Presbyterian Hospital. He has maintained a…
Read MoreTheodore Reiss, MD, MBE, ATSF
Ted began his career with Merck & Co. in Clinical Pharmacology and Pulmonary-Immunology and eventually was responsible for other therapeutic areas within the company including Gastroenterology. Ted also worked at Covance, fostering an integrated approach to drug development, Vanderbilt School of Medicine in Molecular Toxicology and the Clinical and Translational Science Institute (CTSI) and joins…
Read MoreMahendra Shah, PhD
Mahendra Shah, is a highly successful pharmaceutical entrepreneur and executive who has been with Vivo Capital, LLC since March 2010. He currently serving as managing director. Dr. Shah is the founder and executive chairman of Semnur Pharmaceuticals. He previously served as chairman of the board of Essentialis, and currently serves as a board member of…
Read MoreBill Gerhart
Mr. Gerhart is the Chairman and CEO of Patara Pharma, a San Diego-based, clinical stage, biopharmaceutical company he founded to develop a new therapy for the treatment of diseases and conditions associated with inflammation and fibrosis. Prior to Patara, he was the President & CEO of Elevation Pharmaceuticals, a San Diego-based biotech he founded in…
Read More